Skip to the comparison

Head-to-head comparison

Ivim Health vs Hims

At its lowest dated price, Ivim Health costs $139.99 a month (12-month plan, $780 for the medication at this rate): $65 for medication plus a $74.99 membership fee, checked 16 Nov 2026. At its lowest dated price, Hims costs $298 a month: $149 for medication plus a $149 membership fee ($39 for the first month), checked 5 Nov 2026. We don't call either one cheaper. The figures are not like for like: Ivim Health does not say whether it bills its program monthly or up front.

  • No medication with a dated price from both. No price on this page sets the same medicine side by side.
  • Dated prices from Ivim Health only: compounded semaglutide, compounded tirzepatide
  • Dated prices from Hims only: Foundayo pill, Ozempic pill, Wegovy pen, Wegovy pill, Zepbound KwikPen, Zepbound vial

They differ on 3 of the 7 things we track and match on 1. On the other 3, we lack the fact for one of them or both.

Ivim Health and Hims at a glance

We earn a commission on paid links. How we make money

We track prices, terms and availability. We are not clinicians, this page is not medically reviewed, and nothing here is medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.

Hims
Brand only

First year, all in

$3,466–$24,466 cheapest to most expensive product, starting prices

$298/mo total, membership fee $39 for the first month

Price checked 5 Nov 2026

Lawsuit, Jul 2026 6.9/10 VerifiedDose score

Where they differ

Identical rows omitted

More columns to the right. Drag or swipe the table.

Ivim Health compared with Hims. Only the 4 fields where the two differ.
Term
From $/mo $65 compounded semaglutide, 12-month plan Verified 16 Nov 2026 $149 Wegovy pill, brand-name Verified 5 Nov 2026
Membership fee $74.99 Verified 16 Nov 2026 $149/mo, $39 for the first month Verified 5 Nov 2026
Insurance Files insurance claims Not recorded
Model Hybrid Brand only

Rows where both providers state the same thing are left out on purpose. Every price here carries the date we read it from the provider's own pages; a figure with no date reads "not published" rather than being estimated. Not on file for either provider: states covered, time to prescription.

A lower price does not establish clinical suitability or quality of care. We compare what these companies publish about cost and terms, and nothing here measures the medicine or the service behind it.

Regulatory actions on record

Verdict: Ivim Health and Hims sell different medicines. Ivim sells compounded semaglutide and tirzepatide on programs its homepage labels 12 months. Hims sells brand-name drugs, among them the Wegovy, Ozempic and Foundayo pills and the Wegovy pen, month to month. Both add a monthly membership fee and both let you cancel online. Both records carry regulatory actions, listed below with their sources.

What each one sells

Ivim prices compounded semaglutide and compounded tirzepatide. Hims prices brand-name pills and pens, each as a starting monthly figure. Ivim's medicines are made by a compounding pharmacy; Hims sells the manufacturers' own, so the two price lists share no product.

Membership and term

Both charge a monthly membership on top of the medication, and Hims's has a reduced rate for the first month. Ivim's membership must run the length of your program, and Ivim does not say whether its 12-month program is billed monthly or up front. Hims bills month to month.

Questions readers ask

Can I compare Ivim's and Hims's prices directly?

No. Ivim prices compounded drugs on programs labelled 12 months, and Hims prices brand-name drugs month to month. Each figure on this page is the provider's own, with its date and terms.

What is on each provider's regulatory record?

Ivim received an FDA warning letter in February 2026. Hims received FDA warning letters in September 2025 and faces an FTC lawsuit filed in July 2026. Each is listed below with its source and date.

How this site works

How we rate providers

Ratings weigh verified price, total first-year cost, state availability, speed to prescription, cancellation terms and regulatory record. Full scoring rubric.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records, never a provider's marketing claims.

How we make money

When you sign up with a provider through our links, we may earn a referral fee. Fees never influence a rating, a price, or a position in a table. Full advertiser disclosure.